Skip to content

Recovery after fentanyl based TIVA vs dexmedetomedine TIVA using Propofol in short gynaecological procedures

To Study recovery profile after total intravenous anaesthesia with fentanyl -propofol vs dexmedetomedine-propofol during short gynaecological procedures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035315
Enrollment
100
Registered
2021-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

Intervention1: Fentanyl -Propofol: TIVA with Fentanyl -Propofol in short gynaecological procedures Control Intervention1: Dexmedetomedine- propofol: TIVA with Dexmedetomedine- propofol in short gynaec

Sponsors

BARC hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consenting females between 18 to 60 years of age undergoing short gynaecological procedures

Exclusion criteria

Exclusion criteria: 1.Patients with history of epilepsy 2.Severe heart block 3.Morbid obesity 4.Patients on chronic anti-psychotic, sedatives or opioid drugs 5.Patients undergoing laparoscopic surgery 6.Egg allergy and allergy to study drugs 7.Anticipated difficult airway 8. Heart rate 9. Patients on alpha adrenergic receptor blockers.

Design outcomes

Primary

MeasureTime frame
Awakening time -Timepoint: Awakening time is defined as time after stoppage of propofol till the time when patient responds to simple verbal command which will be measured by verbal stimulus to patient every minute after stopping propofol

Secondary

MeasureTime frame
Modified Aldrete Score Timepoint: every 5 minutes after stoppage of propofol infusion till it is â?¥ 9.;PADSS scoreTimepoint: PADSS score will be assessed at 2 and 4 hours after discharge from PACU.

Countries

India

Contacts

Public ContactSheetal Yogesh Chiplonkar

BARC Hospital

drsheetalchiplonkar@gmail.com09920970539

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026